These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants. Jin Y; Andersen G; Yorgov D; Ferrara TM; Ben S; Brownson KM; Holland PJ; Birlea SA; Siebert J; Hartmann A; Lienert A; van Geel N; Lambert J; Luiten RM; Wolkerstorfer A; Wietze van der Veen JP; Bennett DC; Taïeb A; Ezzedine K; Kemp EH; Gawkrodger DJ; Weetman AP; Kõks S; Prans E; Kingo K; Karelson M; Wallace MR; McCormack WT; Overbeck A; Moretti S; Colucci R; Picardo M; Silverberg NB; Olsson M; Valle Y; Korobko I; Böhm M; Lim HW; Hamzavi I; Zhou L; Mi QS; Fain PR; Santorico SA; Spritz RA Nat Genet; 2016 Nov; 48(11):1418-1424. PubMed ID: 27723757 [TBL] [Abstract][Full Text] [Related]
30. An in-depth analysis reveals two new genetic variants on 22q11.2 associated with vitiligo in the Chinese Han population. Tang X; Cheng H; Cheng L; Liang B; Chen M; Zheng X; Xiao F Mol Biol Rep; 2021 Aug; 48(8):5955-5964. PubMed ID: 34350550 [TBL] [Abstract][Full Text] [Related]
31. Genetic variations in nalp1 mRNA expressions in human vitiligo. Deo SS; Bhagat AR; Shah RN Indian J Dermatol; 2011 May; 56(3):266-71. PubMed ID: 21772585 [TBL] [Abstract][Full Text] [Related]
32. Vitiligo--part 1. Tarlé RG; Nascimento LM; Mira MT; Castro CC An Bras Dermatol; 2014; 89(3):461-70. PubMed ID: 24937821 [TBL] [Abstract][Full Text] [Related]
33. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. Jin Y; Birlea SA; Fain PR; Gowan K; Riccardi SL; Holland PJ; Mailloux CM; Sufit AJ; Hutton SM; Amadi-Myers A; Bennett DC; Wallace MR; McCormack WT; Kemp EH; Gawkrodger DJ; Weetman AP; Picardo M; Leone G; Taïeb A; Jouary T; Ezzedine K; van Geel N; Lambert J; Overbeck A; Spritz RA N Engl J Med; 2010 May; 362(18):1686-97. PubMed ID: 20410501 [TBL] [Abstract][Full Text] [Related]
34. Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo. Ren Y; Yang S; Xu S; Gao M; Huang W; Gao T; Fang Q; Quan C; Zhang C; Sun L; Liang Y; Han J; Wang Z; Zhang F; Zhou Y; Liu J; Zhang X PLoS Genet; 2009 Jun; 5(6):e1000523. PubMed ID: 19543371 [TBL] [Abstract][Full Text] [Related]
35. Molecular and cellular basis of depigmentation in vitiligo patients. Delmas V; Larue L Exp Dermatol; 2019 Jun; 28(6):662-666. PubMed ID: 30536790 [TBL] [Abstract][Full Text] [Related]
36. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Alkhateeb A; Stetler GL; Old W; Talbert J; Uhlhorn C; Taylor M; Fox A; Miller C; Dills DG; Ridgway EC; Bennett DC; Fain PR; Spritz RA Hum Mol Genet; 2002 Mar; 11(6):661-7. PubMed ID: 11912181 [TBL] [Abstract][Full Text] [Related]
37. Microphthalmia-associated transcription factor (MITF) locus lacks linkage to human vitiligo or osteopetrosis: an evaluation. Tripathi RK; Flanders DJ; Young TL; Oetting WS; Ramaiah A; King RA; Boissy RE; Nordlund JJ Pigment Cell Res; 1999 Jun; 12(3):187-92. PubMed ID: 10385915 [TBL] [Abstract][Full Text] [Related]